Biogen Files New Drug Application for Aducanumab in Japan
Go back to Biogen Files New Drug Application for Aducanumab in Japan| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.63 -0.4 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.03 | 52 Week High | $333.65 | |||
| Open | $215.74 | 52 Week Low | $223.02 | |||
| Day High | $219.72 | P/E | 27.61 | |||
| Day Low | $214.08 | EPS | $7.81 | |||
| Volume | 778,292 | |||||

